This premier B2B event will bring together experts from all levels of the value chain to ensure maximum knowledge transfer and professional exchange; elaborate on the best practices within the companion diagnostics (CDx) industry as well as academia to discuss, hear and learn about their experiences on latest trends on companion diagnostics (CDx) development, to network and enjoy excellent mix of case studies, interactive panel discussions, speed networking and workshops.

It is an honor and privilege to invite you to participate in this Summit. We look forward to welcoming you at the Summit in Lisbon upcoming October! 

Key Practical Learning Points of the Summit:

• The latest trends of companion diagnostics (CDx) development
• Partnering strategies to achieve successful commercialization of CDx
• Manufacture CDx at the anticipated scale
• Pharmaceutical and Diagnostics Companies Perspectives
• CDx development and pre-launch commercialization costs
• Finding the appropriate business models for CDx companies
• The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
• Introduction of a strategy that can improve the existing models


 

Who should attend? VCEOs, Companion Diagnostics Vice-Presidents, Directors, Chief Medical Officers, Including:

• Associate Director, Companion Diagnostics
• Director, Global Diagnostic
• Senior Director, Worldwide Regulatory Strategy
• Leader, Companion Diagnostic Development
• Senior Director, Biomarkers
• Senior Director, Regulatory Affairs
• Scientific Director, Medical Sciences
• Leader, Companion Diagnostic Development
• Senior Principal Scientist
• Biomarker & Experimental Medicine Leader
• Director Diagnostic & Experimental Pathology
• Head, Personalized Healthcare, Corporate Development & Ventures


 

From Industries Including

• Pharmaceutical, Biotechnology, Research Institutes, CD entities